Companies › Vantive

Vantive

Company Pharma & Medical Devices

Vantive is listed as a company in Pharma & Medical Devices. It has filed 4 comment letters on 3 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
4
Rules commented on
3
First letter
2025-08-30
Latest letter
2026-08-25
Agencies most often
Centers for Medicare & Medicaid Services (4)

Activity by year

20253
20261

Letters

2026

Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program

CMS-2026-2245Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-08-25
Read the letter ↗

2025

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction

CMS-2025-0304Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-09-16
Read the letter ↗

Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

CMS-2025-0240Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-08-30
Read the letter ↗

Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

CMS-2025-0240Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-08-30
Read the letter ↗